Mayo Clinic Laboratories > Commercial laboratories > Featured testing

Featured testing for commercial laboratories

Leading-edge clinically supported diagnostics

The subspecialty testing laboratories at Mayo Clinic support the world’s most sophisticated test menu. Featuring leading-edge diagnostics, many first-in-class assays, and innovative, algorithmic-based approaches, our testing is supported and continuously validated in the Mayo Clinic practice.

120

120 new tests launched in 2023

4,400

4,400 tests and pathology services in our tests catalog

26M

26M tests performed annually

Featured specialty testing

Alzheimer’s disease Alzheimer’s disease
Alzheimer’s disease

Noninvasive and intended for individuals experiencing signs and symptoms of mild cognitive impairment, our plasma-based biomarker offerings evaluate for core biomarkers of Alzheimer’s disease. Our plasma-biomarker menu includes both Mayo Clinic Laboratories-developed testing and testing developed by C2N Diagnostics.

Bile acid malabsorption Bile acid malabsorption
Bile acid malabsorption

Available only at Mayo Clinic Laboratories, our less-invasive combination test pairs fasting 7AC4 serum testing with a random stool collection. This test offers an ideal collection scenario by enabling fasting serum collection during the patient’s medical visit with either at-home or in-clinic spot stool collection that is returned to the laboratory.

Hereditary movement disorders Hereditary movement disorders
Hereditary movement disorders

Our comprehensive Parkinson’s disease gene panel was developed by a multidisciplinary team of clinicians, geneticists, and laboratory testing experts. It includes genes known for causing Parkinson’s disease as well as genes that increase the likelihood of developing the condition.

Hyperoxaluria Hyperoxaluria
Hyperoxaluria

By quantifying excretion of oxalate, glycolate, glycerate, and 4-hydroxy-2-oxoglutarate, our hyperoxaluria panel can distinguish between the two forms of hyperoxaluria. The results of this assay are reported with interpretive comments and include recommendations for molecular testing.

Malabsorption syndromes Malabsorption syndromes
Malabsorption syndromes

Our comprehensive malabsorption panel expedites and streamlines the diagnostic testing experience by evaluating for four disease markers with just one stool sample. Ideal for pediatric patients, the test quickly rules in or out numerous causes of GI conditions.

Neurological cancer Neurological cancer
Neurological cancer

Our MayoComplete next-generation sequencing panel evaluates mutations and rearrangements in 160 genes, including most abnormalities described by the World Health Organization 20211 classifications. It assesses mutations in 89 genes and rearrangements in 81 genes, including 104 fusions and 29 transcript variants.

Ovarian cancer Ovarian cancer
Ovarian cancer

Our folate receptor alpha test can facilitate the diagnosis of a type of ovarian cancer that may be eligible for treatment with an anti-folate receptor 1 protein antibody.

Peripheral neuropathy Peripheral neuropathy
Peripheral neuropathy

When there is evidence of a demyelinating neuropathy, our antibody evaluation helps distinguish between different disease states. Our panel includes only those biomarkers that correlate with demyelinating neuropathies. Including wide-ranging, relevant antibodies with high clinical specificity minimizes unnecessary testing and the potential for false-positive results.

Sarcoma Sarcoma
Sarcoma

Our next-generation sequencing sarcoma panel analyzes rearrangements for 138 genes to facilitate the diagnosis of soft tissue and bone tumors based on the observed gene fusions.

Comprehensive test menu Comprehensive test menu
Comprehensive test menu

The subspecialty testing laboratories at Mayo Clinic support the world’s most sophisticated test menu. Featuring leading-edge diagnostics, many first-in-class assays, and innovative, algorithmic-based approaches, our testing is supported and continuously validated in the Mayo Clinic practice.

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.